Peroxisome Proliferator–Activated Receptor β/δ Alleviates Early Brain Injury After Subarachnoid Hemorrhage in Rats
Author(s) -
Zhipeng Teng,
Li Jiang,
Qin Hu,
Yue He,
ZhenNi Guo,
Yue Wu,
Zhijian Huang,
Fang Cao,
Chongjie Cheng,
Xiaochuan Sun,
Zongduo Guo
Publication year - 2015
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.115.011701
Subject(s) - medicine , extravasation , subarachnoid hemorrhage , downregulation and upregulation , blood–brain barrier , evans blue , peroxisome proliferator activated receptor , traumatic brain injury , apoptosis , agonist , anesthesia , pathology , receptor , endocrinology , central nervous system , biology , biochemistry , psychiatry , gene
Early brain injury is proposed to be the primary cause of the poor outcome after subarachnoid hemorrhage (SAH), which is closely related to the neural apoptosis. To date, the relationship between peroxisome proliferator-activated receptor β/δ (PPARβ/δ) and nuclear factor-κB/matrix metalloproteinase-9 (NF-κB/MMP-9) pathway, both of which are closely related to apoptotic effects, has been poorly studied in SAH. The present study was undertaken to evaluate the effects of PPARβ/δ on early brain injury and NF-κB/MMP-9 pathway after SAH in rats.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom